STAAR Surgical | STAA - Cash And Equivalent


STAAR Surgical reported $153.15M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Bausch Health Companies USD 1.83B 526M Jun/2026
Boston Scientific USD 539M 914M Jun/2026
Cerus USD 19.96M 4.29M Dec/2025
Cooper Companies USD 124.9M 14.3M Dec/2025
J&J USD 20.42B 1.27B Jun/2026
Merit Medical Systems USD 448.7M 39.38M Jun/2026
Novartis USD 7.62B 739M Jun/2026
OraSure Technologies USD 176.96M 22.31M Mar/2026
Orthofix International USD 103.81M 16.47M Jun/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Utah Medical Products USD 84.27M 2.09M Sep/2025